Holen Sie sich die Stockscreener-App
5.13
0.98%
0.05
Handel nachbörslich:
5.14
0.010
+0.19%
Schlusskurs vom Vortag:
$5.08
Offen:
$5.11
24-Stunden-Volumen:
1.45M
Relative Volume:
0.56
Marktkapitalisierung:
$168.26M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-87.23M
KGV:
-1.7273
EPS:
-2.97
Netto-Cashflow:
$-82.77M
1W Leistung:
+1.18%
1M Leistung:
+331.09%
6M Leistung:
+308.76%
1J Leistung:
-43.00%
1-Tages-Spanne:
$4.94
$5.36
1-Wochen-Bereich:
$4.33
$5.36
52-Wochen-Spanne:
$0.8801
$9.935
Pepgen Inc Stock (PEPG) Company Profile
Firmenname
Pepgen Inc
Sektor
Branche
Telefon
703-456-8000
Adresse
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Vergleichen Sie PEPG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
5.13 | 349.19M | 0 | -87.23M | -82.77M | -2.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
403.30 | 104.83B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
600.00 | 63.59B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.35 | 60.43B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
800.00 | 48.45B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
343.87 | 37.91B | 4.56B | -176.77M | 225.30M | -1.7177 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-09 | Eingeleitet | Guggenheim | Buy |
| 2024-12-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-07-31 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-21 | Eingeleitet | H.C. Wainwright | Buy |
Pepgen Inc Aktie (PEPG) Neueste Nachrichten
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PepGen Inc. (PEPG) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Is PepGen Inc. trending in predictive chart modelsTrade Performance Summary & Safe Swing Trade Setups - newser.com
Why PepGen Inc. stock remains resilientEarnings Overview Report & Long Hold Capital Preservation Plans - newser.com
Is PepGen Inc. stock poised for growthWeekly Risk Summary & Daily Price Action Insights - newser.com
Is PepGen Inc. reversing from oversold territoryWeekly Investment Report & AI Optimized Trade Strategies - newser.com
PepGen says FREEDOM clinical study achieves all key objectives - MSN
What data driven models say about PepGen Inc.’s futureWeekly Gains Report & Daily Profit Focused Screening - newser.com
Can trapped investors hope for a rebound in PepGen Inc.Earnings Beat & Safe Swing Trade Setups - newser.com
Using Bollinger Bands to evaluate PepGen Inc.2025 AllTime Highs & Accurate Entry/Exit Alerts - newser.com
Can momentum traders help lift PepGen Inc.Market Growth Summary & Verified Entry Point Detection - newser.com
Is PepGen Inc. stock gaining market shareJuly 2025 Recap & Pattern Based Trade Signal System - newser.com
PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle So - PharmiWeb.com
PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society - Business Wire
Major Stakeholder Makes Bold Move with PepGen Inc. Stock Purchase! - TipRanks
PepGen Highlights Progress in Therapy for DM1 - TipRanks
PepGen Inc. Stock (PEPG) Opinions on Recent Insider Buying and Offering Closure - Quiver Quantitative
PepGen Inc. (PEPG) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Massive Investment Alert: PepGen Inc. Stock Sees Major Buy-In! - TipRanks
Anaphylaxis drives Larimar’s setback, weak efficacy behind MoonLake’s: Clinical Report - BioCentury
PepGen Inc. (PEPG) Rating Upgraded With 135% Upside on FREEDOM Data - Insider Monkey
PepGen (PEPG) Price Target Increased by 21.95% to 8.50 - Nasdaq
Wedbush Cuts Price Target on PepGen to $8 From $9, Keeps Outperform Rating - MarketScreener
What analysts say about PepGen Inc stockInstitutional Buying Trends & Follow Top Performers in the Community - earlytimes.in
PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters Option to Purchase Additional Shares - MarketScreener
Top Biotech Stocks To Watch TodaySeptember 25th - MarketBeat
What is Wedbush’s Estimate for PepGen FY2028 Earnings? - Defense World
PepGen Stock Plummets on Secondary Offering News - timothysykes.com
A Look at PepGen (PEPG) Valuation After Positive Clinical Data and $100M Equity Raise - Yahoo Finance
PepGen Inc. Announces Public Offering Agreement - The Globe and Mail
PepGen raises $115 million in public offering to fund clinical trials - Investing.com Nigeria
PEPG News Today | Why did PepGen stock drop today? - MarketBeat
MBX, uniQure among biotechs raising nine-figure sums: Public Equity Report - BioCentury
Finanzdaten der Pepgen Inc-Aktie (PEPG)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.68%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):